期刊文献+

硫酸软骨素酶ABCⅠ分泌型真核表达质粒的构建 被引量:1

The construction of a secretary eukaryotic expression plasmid of chondroitinase ABC Ⅰ
下载PDF
导出
摘要 目的建立硫酸软骨素酶ABC Ⅰ(ChABC Ⅰ)的分泌型真核表达载体,并在胶质瘤细胞系中对其表达情况进行观察。方法以真核表达载体pCDNA3.1/V5/HIS A为载体,将基底膜40蛋白信号肽编码区和ChABC Ⅰ成熟肽段编码区串联插入其多克隆位点,构建分泌型真核表达质粒pCDNA-BMS-CABCⅠ。采用该质粒转染人胶质瘤细胞系TJ905,培养3 d后将培养液上清液行SDS-PAGE和免疫印迹分析。结果考马斯亮蓝染色显示有新条带出现,条带的相对分子质量大小与理论值一致,免疫印迹检测显示有V5免疫反应性特异性条带出现。结论该真核表达载体可介导硫酸软骨素酶ABC Ⅰ在神经胶质细胞来源的细胞中以分泌蛋白形式表达。 Objective To construct a secretary eukaryotic expression plasmid for chondroitinase ABC Ⅰ , and observe the expression of the target protein in a glioma cell line TJ905. Methods The DNA fragments encoding the signal peptide of basilar membrane 40 (BM40) as well as the mature fragment of chondroitinase ABC Ⅰ were inserted into the eukaryotic expression vector pCDNA3.1/V5/HIS A in series to construct the secretary eukaryotic expression plasmid pCDNA-BMS-CABC Ⅰ . Then the plasmid was used to transfect the glioma cell line TJ905, and after 3 d, the supernatant of the culture media was collected and analysed by sodium dodecyl sulfate- polyacrytamide get electrophoresis (SDS- PAGE) and Western blotting. Results On polyacrylamide gel electrophoresis (PAGE) gel, a new band corresponding to the theoretic molecular weight was spotted. Western blotting showed a specific band of V5 immunoreactivity. Conclusion The newly constructed plasmid can mediate the eukaryotic expression of chondroitinase ABC Ⅰ in secretary manner.
出处 《中国现代神经疾病杂志》 CAS 2010年第4期479-482,共4页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 天津市高等学校科技发展基金重点项目(项目编号:2004ZD06) 天津市科技支撑计划重点项目(项目编号:07ZCKFSF00800) 天津市高等学校科技发展基金计划项目(项目编号:20060202)
关键词 软骨素硫酸酶类 质粒 转染 神经胶质瘤 免疫印迹法 Chondroitinsulfatases Plasmids Transfection Glioma Immunoblotting
  • 相关文献

参考文献8

  • 1Cafferty WB, Yang SH, Duffy PJ, et al. Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci, 2007, 27: 2176-2185.
  • 2Tsai EC, Tator CH. Neuroprotection and regeneration strategies for spinal cord repair. Curr Pharm Des, 2005, 11:1211-1222.
  • 3Barritt AW, Davies M, Marchand F, et ai. Chondroitinase ABC promotes sprouting of intact and injuried spinal systems after spinal cord injury. J Neurosci, 2006, 26:10856-10867.
  • 4Huang WC, Kuo WC, Cherng JH, et al. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun, 2006, 349:963-968.
  • 5Li HP, Homma A, Sango K, et al. Regeneration of nigrostriatal dopaminergic axons by degradation of chondroitin sulfate is accompanied by elimination of the fibrotic scar and glia limitans in the lesion site. J Neurosci Res, 2007, 85:536-547.
  • 6HoLden P, Keene DR, Lunstrum GP, et al. Secretion of cartilage oligomeric matrix protein is affected by the signal peptide. J Biol Chem, 2005, 280:17172-17179.
  • 7Prabhakar V, Capila I Bosques CJ, et al. Chondroitinase ABC I from Proteus vulgaris: cloning, recombinant expression and active site identification. Biochem J, 2005, 386(Pt 1):103-112.
  • 8Carulli D, Laabs T, Geller HM, et al. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol, 2005, 15:116-120.

同被引文献63

  • 1蔡苏兰,阎浩林,何汉洲.温和气单孢菌YH311硫酸软骨素裂解酶的分离纯化与固定化[J].生物工程学报,2004,20(4):584-589. 被引量:2
  • 2熊双丽,金征宇.不同分子量硫酸软骨素的制备和抗氧化活性探讨[J].中成药,2006,28(9):1343-1346. 被引量:8
  • 3林雪松,侯立中,杨同书.硫酸软骨素裂解酶ABC的制备[J].白求恩医科大学学报,1997,23(1):104-105. 被引量:5
  • 4Bernfield M, Gotte M, Park PW, et al. Functionsof cell surface heparan sulfate proteoglycans. Annu Rev Biochem, 1999, 68(1): 729-777.
  • 5Sugahara K, Mikami T, Uyama T, et al. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curre Opin Strut Biol, 2003, 13(5): 612-620.
  • 6Bao X, Nishimura S, Mikami T, et al. Chondroitin sulfate/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of L-iduronic acid than those from adult pig brain, exhibit neuritogenic and growth factor binding activities. J Biol Chem, 2004, 279(11): 9765-9776.
  • 7Lamari FN, Karamanos NK. Structure of chondroitin sulfate. Adv Pharmacol, 2006, 53: 33-48.
  • 8Lauder RM. Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. Compl Ther Med, 2009, 17(1): 56-62.
  • 9Aich U, Shriver Z, Tharakaraman inhibition of heparinase by glycosaminoglycans: a tool to contamination. Anal Chem, K. Competitive persulfonated detect heparin 2011, 83(20):7815-7822.
  • 10Garron ML, Cygler M. Structural and mechanistic classification of uronic acid-containing polysaccharide lyases. Glycobiology, 2010, 20(12) 1547-1573.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部